VENUS REMEDIES
|
The Current P/S Ratio of VENUS REMEDIES is 2.81.
| Share Price | ₹1,602.3 | Jun 09,2026 |
| Market Cap | ₹2,147.0 Cr | |
| Sales-TTM | ₹764.3 Cr | TTM-Consolidated Results |
| Price/Sales | 2.81x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of VENUS REMEDIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,147.0 Cr] as on Jun 09,2026
(/) Sales [ ₹764.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.81x ]
Thus, for VENUS REMEDIES , the investors are currently willing to pay '2.81 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VENUS REMEDIES !
The chart below summarizes the trend in P/S Ratio of VENUS REMEDIES over the last five years.
Historical PS (Price/Sales) ratio chart of VENUS REMEDIES
PS Ratio Performance Analysis for VENUS REMEDIES
- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.59x.
- VENUS REMEDIES 's operated at median p/e ratio of 0.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2024 at 0.73x.
- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2023 of 0.39x.
How does VENUS REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| VENUS REMEDIES | 764.3 | 2.81 | 2,147.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.33 | 428,785.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.69 | 176,242.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.81 | 151,058.0 |
| CIPLA LTD | 28,162.6 | 3.95 | 111,180.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.15 | 106,149.0 |
| MANKIND PHARMA LTD | 14,277.6 | 6.86 | 97,952.3 |
| LUPIN LTD | 27,958.0 | 3.68 | 102,818.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.07 | 110,474.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.49 | 83,654.2 |
| LAURUS LABS LTD | 6,812.9 | 10.98 | 74,827.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VENUS REMEDIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.49x |
| Max industry PS | 16.69x |
| Median industry PS | 4.07x |
| Average industry PS | 6.62x |
You may also like the below Video Courses